Short answer
BALCHEM CORP (BCPC) filed its Q2 2026 10-Q quarterly report on Jul 31, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $284M (up 11.2% year over year) with net income of $45M.
Q2 2026 key financials · XBRL
- Revenue
- $284M
- +11.2% YoY · +4.9% QoQ
- Net income
- $45M
- +16.6% YoY · +10.7% QoQ
- Operating margin
- 20.9%
- Gross margin
- 36.5%
- EPS (diluted)
- $1.38
- +17.9% YoY · +10.4% QoQ
Source: XBRL data from the BALCHEM CORP (BCPC) Q2 2026 10-Q on SEC EDGAR. USD.
BALCHEM CORP Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $283.997M, up 11.2% YoY from $255.467M
- Operating margin 20.9% vs 20.1%; gross margin 36.5% vs 36.4%
- Best segment Animal Nutrition & Health: sales $64.454M, up 15.0%; earnings $5.227M, up 48.7%
- Operating cash flow $86.772M, up 3.7%; cash declined to $63.174M from $74.570M
- Capital deployment: $44.484M share repurchases, $30.772M dividends, $17.138M capital investments
- Headwinds: geopolitical tensions, tariffs, energy, raw-material and freight-cost volatility; no material future cash-flow effect expected from tariffs
Risk Factors
- No material risk-factor changes since the December 31, 2025 Form 10-K
- Carried-forward regulatory and compliance risks unchanged from the annual filing
- Carried-forward operational and competitive risks unchanged from the annual filing
- Carried-forward financial and liquidity risks unchanged from the annual filing
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other BALCHEM CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.